No Arabic abstract
Breast cancer is one of the leading fatal disease worldwide with high risk control if early discovered. Conventional method for breast screening is x-ray mammography, which is known to be challenging for early detection of cancer lesions. The dense breast structure produced due to the compression process during imaging lead to difficulties to recognize small size abnormalities. Also, inter- and intra-variations of breast tissues lead to significant difficulties to achieve high diagnosis accuracy using hand-crafted features. Deep learning is an emerging machine learning technology that requires a relatively high computation power. Yet, it proved to be very effective in several difficult tasks that requires decision making at the level of human intelligence. In this paper, we develop a new network architecture inspired by the U-net structure that can be used for effective and early detection of breast cancer. Results indicate a high rate of sensitivity and specificity that indicate potential usefulness of the proposed approach in clinical use.
With an aging and growing population, the number of women requiring either screening or symptomatic mammograms is increasing. To reduce the number of mammograms that need to be read by a radiologist while keeping the diagnostic accuracy the same or better than current clinical practice, we develop Man and Machine Mammography Oracle (MAMMO) - a clinical decision support system capable of triaging mammograms into those that can be confidently classified by a machine and those that cannot be, thus requiring the reading of a radiologist. The first component of MAMMO is a novel multi-view convolutional neural network (CNN) with multi-task learning (MTL). MTL enables the CNN to learn the radiological assessments known to be associated with cancer, such as breast density, conspicuity, suspicion, etc., in addition to learning the primary task of cancer diagnosis. We show that MTL has two advantages: 1) learning refined feature representations associated with cancer improves the classification performance of the diagnosis task and 2) issuing radiological assessments provides an additional layer of model interpretability that a radiologist can use to debug and scrutinize the diagnoses provided by the CNN. The second component of MAMMO is a triage network, which takes as input the radiological assessment and diagnostic predictions of the first networks MTL outputs and determines which mammograms can be correctly and confidently diagnosed by the CNN and which mammograms cannot, thus needing to be read by a radiologist. Results obtained on a private dataset of 8,162 patients show that MAMMO reduced the number of radiologist readings by 42.8% while improving the overall diagnostic accuracy in comparison to readings done by radiologists alone. We analyze the triage of patients decided by MAMMO to gain a better understanding of what unique mammogram characteristics require radiologists expertise.
Multi-instance multi-label (MIML) learning is a challenging problem in many aspects. Such learning approaches might be useful for many medical diagnosis applications including breast cancer detection and classification. In this study subset of digiPATH dataset (whole slide digital breast cancer histopathology images) are used for training and evaluation of six state-of-the-art MIML methods. At the end, performance comparison of these approaches are given by means of effective evaluation metrics. It is shown that MIML-kNN achieve the best performance that is %65.3 average precision, where most of other methods attain acceptable results as well.
Purpose: To determine whether deep learning models can distinguish between breast cancer molecular subtypes based on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Materials and methods: In this institutional review board-approved single-center study, we analyzed DCE-MR images of 270 patients at our institution. Lesions of interest were identified by radiologists. The task was to automatically determine whether the tumor is of the Luminal A subtype or of another subtype based on the MR image patches representing the tumor. Three different deep learning approaches were used to classify the tumor according to their molecular subtypes: learning from scratch where only tumor patches were used for training, transfer learning where networks pre-trained on natural images were fine-tuned using tumor patches, and off-the-shelf deep features where the features extracted by neural networks trained on natural images were used for classification with a support vector machine. Network architectures utilized in our experiments were GoogleNet, VGG, and CIFAR. We used 10-fold crossvalidation method for validation and area under the receiver operating characteristic (AUC) as the measure of performance. Results: The best AUC performance for distinguishing molecular subtypes was 0.65 (95% CI:[0.57,0.71]) and was achieved by the off-the-shelf deep features approach. The highest AUC performance for training from scratch was 0.58 (95% CI:[0.51,0.64]) and the best AUC performance for transfer learning was 0.60 (95% CI:[0.52,0.65]) respectively. For the off-the-shelf approach, the features extracted from the fully connected layer performed the best. Conclusion: Deep learning may play a role in discovering radiogenomic associations in breast cancer.
The International Symposium on Biomedical Imaging (ISBI) held a grand challenge to evaluate computational systems for the automated detection of metastatic breast cancer in whole slide images of sentinel lymph node biopsies. Our team won both competitions in the grand challenge, obtaining an area under the receiver operating curve (AUC) of 0.925 for the task of whole slide image classification and a score of 0.7051 for the tumor localization task. A pathologist independently reviewed the same images, obtaining a whole slide image classification AUC of 0.966 and a tumor localization score of 0.733. Combining our deep learning systems predictions with the human pathologists diagnoses increased the pathologists AUC to 0.995, representing an approximately 85 percent reduction in human error rate. These results demonstrate the power of using deep learning to produce significant improvements in the accuracy of pathological diagnoses.
Breast cancer is one of the most common cancers in women worldwide, and early detection can significantly reduce the mortality rate of breast cancer. It is crucial to take multi-scale information of tissue structure into account in the detection of breast cancer. And thus, it is the key to design an accurate computer-aided detection (CAD) system to capture multi-scale contextual features in a cancerous tissue. In this work, we present a novel graph convolutional neural network for histopathological image classification of breast cancer. The new method, named multi-scale graph wavelet neural network (MS-GWNN), leverages the localization property of spectral graph wavelet to perform multi-scale analysis. By aggregating features at different scales, MS-GWNN can encode the multi-scale contextual interactions in the whole pathological slide. Experimental results on two public datasets demonstrate the superiority of the proposed method. Moreover, through ablation studies, we find that multi-scale analysis has a significant impact on the accuracy of cancer diagnosis.